JA Desmeules

Genetic polymorphisms and drug interactions modulating CYP2D6 and CYP3A activities have a major effect on oxycodone analgesic efficacy and safety

Youssef Daali, Michel Wagner, Gérard Hopfgartner et al. · British Journal of Pharmacology · 2010 · 200 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

The effects of CYP2D6 and CYP3A activities on the pharmacokinetics of immediate release oxycodone

Youssef Daali, Michel Wagner, Gérard Hopfgartner et al. · British Journal of Pharmacology · 2010 · 165 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Coadministration of ticagrelor and ritonavir: Toward prospective dose adjustment to maintain an optimal platelet inhibition using the PBPK approach

Niloufar Marsousi, Pierre Fontana, Serge Rudaz et al. · Clinical Pharmacology & Therapeutics · 2016 · 41 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +15

Prediction of Metabolic Interactions With Oxycodone via CYP2D6 and CYP3A Inhibition Using a Physiologically Based Pharmacokinetic Model

Niloufar Marsousi, Youssef Daali, Serge Rudaz et al. · CPT Pharmacometrics & Systems Pharmacology · 2014 · 16 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17